cancer research

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma

Autores e Afiliações:
Ricardo Celestino^1,2,3,4, Torfinn Nome^3,5, Ana Pestana^1,2,6, Andreas M. Hoff^3,5, A. Pedro Gonçalves^1,6,7, Luísa Pereira^1,2, Bruno Cavadas^1,2, Catarina Eloy^1,2, Trine Bjøro^8,9, Manuel Sobrinho-Simões^1,2,10,11, Rolf I. Skotheim^3,5, Paula Soares^1,2,10

¹- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal;

Tags:

biomarkers

thyroid carcinoma

cancer research

Ricardo Celestino

Paula Soares

ASPIC

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma

<Voltar à listagem

Authors and affiliations:
Ricardo Celestino^1,2,3,4, Torfinn Nome^3,5, Ana Pestana^1,2,6, Andreas M. Hoff^3,5, A. Pedro Gonçalves^1,6,7, Luísa Pereira^1,2, Bruno Cavadas^1,2, Catarina Eloy^1,2, Trine Bjøro^8,9, Manuel Sobrinho-Simões^1,2,10,11, Rolf I. Skotheim^3,5, Paula Soares^1,2,10

Formulário de procura

cancer research

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma

VIII Workshop on Cancer Research: Biological and Molecular Basis

VIII Workshop on Cancer Research: Biological and Molecular Basis

BACR Precision Medicine and Cancer Models: Developing strategies to enhance clinical response

BACR Precision Medicine and Cancer Models: Developing strategies to enhance clinical response

Molecular Analysis for Personalised therapy (MAP) 2017

Molecular Analysis for Personalised therapy (MAP) 2017

ILCA 2017 - The International Liver Cancer Association's 11th Annual Conference

ILCA 2017 - The International Liver Cancer Association's 11th Annual Conference

Parceiros